Keystone Symposia

This meeting took place in 2013

Here are the related meetings in 2021:
Asthma: New Discoveries and Therapies in the Age of COVID (EK9)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Pathogenic Processes in Asthma and COPD (J2)

Organizer(s) Marsha Wills-Karp, Jay K. Kolls and Sebastian L. Johnston
January 10—15, 2013
Santa Fe Community Convention Center • Santa Fe, NM USA
Abstract Deadline: Sep 10, 2012
Late Abstract Deadline: Oct 10, 2012
Scholarship Deadline: Sep 10, 2012
Early Registration Deadline: Nov 8, 2012

Supported by the Directors' Fund

Summary of Meeting:
Chronic obstructive pulmonary disease (COPD) and asthma continue to be important causes of morbidity, mortality, and healthcare costs worldwide. However, the underlying causes of asthma and COPD remain poorly understood, even as the incidence of such diseases continues to increase. Recent discoveries have uncovered strong associations between both lung function and immune responses in early life and the subsequent development of persistent asthma and chronic airway obstruction in adulthood. However, to date, no meeting has taken advantage of these recent discoveries. The overall goal of this meeting is to draw together investigators from multiple disciplines doing work relevant to understanding the genetic, epigenetic and environmental factors and mechanisms that affect the development of asthma and COPD. The specific goals of the meeting are to: 1) explore recent insights into the genetic and epigenetic origins of asthma and COPD; 2) understand the relationship between early life environmental exposures and impaired lung function throughout life; 3) understand the relationship between lung infections as well as changes in the intestinal microbiome and the development of chronic lung diseases; 4) understand the role of newly described innate immune cell populations and pathways in the development of lung inflammation; 5) understand recent insights into the mechanisms of lung development, repair and remodeling; and 6) explore unique pathways of resolution of lung inflammation. By bringing together a critical mass of multidisciplinary researchers, this symposium should provide an ideal forum for exploring novel prevention and treatment strategies for these chronic respiratory diseases based on the identification of the genetic and environmental factors that interactively cause these disorders. Moreover, this meeting will serve to provide an in-depth exposure for junior investigators (graduate students and post-docs) to a fast-moving, fruitful area of medical research, as well as enticing such scientists into the field. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Type 2 Immunity: Initiation, Maintenance, Homeostasis and Pathology, which will share a keynote address and two plenary sessions with this meeting.

View Meeting Program


First Time Meeting Travel Award Recipients

Blythe Elena Janowiak
St. Louis University, USA

Keystone Symposia Future of Science Fund Scholarship Recipients

Tamlyn Peel
Imperial College London, UK

Batika Rana
King's College London, UK